dc.contributor.author | Chemtai Mungo, Cirilus Ogollah Osongo, Jeniffer Ambaka, Magdalene A Randa, Jackton Omoto, Craig R Cohen, Megan Huchko | |
dc.date.accessioned | 2020-09-04T09:21:03Z | |
dc.date.available | 2020-09-04T09:21:03Z | |
dc.date.issued | 2020-07 | |
dc.identifier.uri | https://repository.maseno.ac.ke/handle/123456789/2724 | |
dc.description.abstract | PURPOSE
The WHO now recommends thermal ablation as an alternative to cryotherapy within “screen-and-treat” cervical cancer programs in low- and middle-income countries (LMICs). We conducted a safety and acceptability clinical trial of thermal ablation in a Kenyan Ministry of Health hospital among women living with HIV (WLWH; ClinicalTrials.gov identifier: NCT04191967).
METHODS
Between August 2019 and February 2020, WLWH age 25-65 years underwent human papillomavirus (HPV) self-collection in western Kenya. HPV-positive women underwent visual inspection with acetic acid, biopsy, and treatment with thermal ablation performed by a nonphysician clinician, if eligible by standard guidelines. A questionnaire was administered after treatment to assess for pain and treatment acceptability. Adverse events (AEs) were evaluated 4-6 weeks after treatment with a standardized grading tool.
RESULTS
A … | en_US |
dc.publisher | American Society of Clinical Oncology | en_US |
dc.title | Safety and Acceptability of Thermal Ablation for Treatment of Human Papillomavirus Among Women Living With HIV in Western Kenya | en_US |
dc.type | Article | en_US |